HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph J McDonald Selected Research

Sorafenib (BAY 43-9006)

10/2020Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph J McDonald Research Topics

Disease

4Neoplasms (Cancer)
10/2020 - 07/2002
1Arthritis (Polyarthritis)
09/2010
1Cardiovascular Diseases (Cardiovascular Disease)
09/2010
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2010
1Breast Neoplasms (Breast Cancer)
10/2005
1Neoplasm Metastasis (Metastasis)
07/2002

Drug/Important Bio-Agent (IBA)

2Matrix Metalloproteinases (MMPs)IBA
09/2010 - 07/2002
1Sorafenib (BAY 43-9006)FDA Link
10/2020
1ErbB Receptors (EGF Receptor)IBA
04/2016
1N- hydroxy- 1- (2- methoxyethyl)- 4- ((4- (4- (trifluoromethoxy)phenoxy)phenyl)sulfonyl)piperidine- 4- carboxamideIBA
09/2010
1Matrix Metalloproteinase InhibitorsIBA
09/2010
1piperidineIBA
09/2010
1SulfonesIBA
09/2010
1Paclitaxel (Taxol)FDA LinkGeneric
10/2005